Guillén, S. M., García, J. E. L., Berenguer, J. B., Sesmero, J. M. M., Gomis, S. C., Graefehain, R., . . . García, F. J. P. (2017). Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain. Farmacia Hospitalaria.
Citação norma ChicagoGuillén, Santiago Moreno, Juan Emilio Losa García, Juan Berenguer Berenguer, José Manuel Martínez Sesmero, Santiago Cenoz Gomis, Ruth Graefehain, David López Sánchez-Cambronero, and Francisco Javier Parrondo García. "Cost-utility Analysis of the Fixed-dose Combination of Dolutegravir/abacavir/lamivudine As Initial Treatment of HIV+ Patients in Spain." Farmacia Hospitalaria 2017.
Citação norma MLAGuillén, Santiago Moreno, et al. "Cost-utility Analysis of the Fixed-dose Combination of Dolutegravir/abacavir/lamivudine As Initial Treatment of HIV+ Patients in Spain." Farmacia Hospitalaria 2017.